Profitelligence Profitelligence · Filing Ledger Open TWST research →

Form 8-K · Current Report · Filed 2026-08-19

Twist Bioscience Files Prospectus Supplement for Share Resale

Twist Bioscience Corporation has filed a prospectus supplement to register the resale of shares issuable pursuant to a Stock Purchase Agreement with Invenra Inc.

Filer
Twist Bioscience Corporation TWST · NASDAQ
Filed
Accession
0001104659-26-098830
CIK
0001581280
Signal
Medium impactHealthcare

Details

The filing includes an opinion from Orrick, Herrington & Sutcliffe LLP as Exhibit 5.1.

Items reported

Item events

Reported Item

Securities Purchase Agreement

Market reaction

Close before filing

$116.10

Next session

+17.4%

Since filing

+34.0%

Latest close

$155.56

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TWST reporting the same item, with the next session's move:

Twist Bioscience Selected as Evaluator for Anthropic's AI-Driven Protein Design Campaign+14.5%
Twist Bioscience Announces $300 Million Public Offering of Common Stock+9.7%
Twist Bioscience Reports 23% Revenue Growth and Raises Full-Year Guidance+8.6%
Twist Bioscience Reports Strong Q2 2026 Financial Results and Raises Guidance-6.1%
Twist Bioscience Corporation Announces Share Issuance in Stock Purchase Agreements+11.8%

Insider tape

Within 45 days of this filing, TWST insiders reported 44 Form 4 transactions — net selling of $36.8M.

Full TWST insider history →

About Twist Bioscience Corporation

Twist Bioscience Corporation is a synthetic biology and biotechnology company that develops and commercializes DNA-based products built on its proprietary silicon-based synthesis platform. Twist Bioscience Corporation’s core offerings include synthetic genes, DNA oligos, oligo pools, library preparation tools, antibody libraries, and other workflow products used in next-generation sequencing, gene editing, drug discovery, diagnostics, and research. The company serves customers across academic, pharmaceutical, biotech, industrial, and agricultural markets, providing scalable tools for applications that require precise, high-quality synthetic DNA. Its platform supports high-throughput manufacturing and a broad product portfolio that helps researchers and developers design, test, and advance biological innovation across multiple life science segments. Headquartered in South San Francisco, California, Twist Bioscience Corporation plays a specialized role in the global market for synthetic DNA and genomics-enabled research tools.

Exchange NASDAQ Industry Diagnostics & Research Company website ↗

Never miss another TWST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts